Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ASRT
ASRT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ASRT News
Assertio Holdings to Release Q4 and Full Year 2025 Financial Results
Mar 03 2026
Businesswire
Healthcare Stocks with Strong Earnings Momentum Earn A+ EPS Revision Grades
Jan 16 2026
seekingalpha
Assertio Holdings Regains Nasdaq Compliance with Minimum Bid Price Rule
Jan 12 2026
Newsfilter
Assertio Reports Positive Results for Same-Day Dosing of Rolvedon in Clinical Trial
Jan 09 2026
Newsfilter
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing
Jan 09 2026
Businesswire
Assertio Holdings declares a 1-for-15 reverse stock split.
Dec 22 2025
SeekingAlpha
KalVista, Health Catalyst, and Bio-Techne Experience After-Hours Increases Following Earnings Reports
Nov 11 2025
NASDAQ.COM
Assertio (ASRT) Exceeds Q3 Earnings and Revenue Projections
Nov 10 2025
NASDAQ.COM
Assertio Shares Climb Following Revenue Surprise
Nov 10 2025
SeekingAlpha
Investor Alert: 3-Day Deadline in Securities Lawsuit Involving Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) – Hagens Berman
Sep 21 2025
Globenewswire
URGENT: Berger Montague Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Reach Out Before September 24, 2025
Sep 18 2025
Globenewswire
Assertio Unveils Groundbreaking Real-World Study on Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
Sep 15 2025
Newsfilter
DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
Sep 12 2025
PRnewswire
SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025
Sep 08 2025
PRnewswire
NASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action
Aug 19 2025
PRnewswire
SHAREHOLDER NOTICE: Berger Montague Informs Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors About Class Action Lawsuit Deadline
Aug 18 2025
Globenewswire
Show More News
